Chemoinformaics analysis of Alpinum Isoflavone
| Molecular Weight | 336.343 | nRot | 1 |
| Heavy Atom Molecular Weight | 320.215 | nRig | 23 |
| Exact Molecular Weight | 336.1 | nRing | 4 |
| Solubility: LogS | -3.291 | nHRing | 2 |
| Solubility: LogP | 4.395 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 17 |
| nHA | 5 | APOL | 48.0787 |
| nHD | 2 | BPOL | 20.3913 |
| QED | 0.7 |
| Synth | 2.839 |
| Natural Product Likeliness | 2.258 |
| NR-PPAR-gamma | 0.983 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.028 |
| Pgp-sub | 0.001 |
| HIA | 0.011 |
| CACO-2 | -4.698 |
| MDCK | 0.0000207 |
| BBB | 0.015 |
| PPB | 1.00089 |
| VDSS | 0.394 |
| FU | 0.00964094 |
| CYP1A2-inh | 0.917 |
| CYP1A2-sub | 0.213 |
| CYP2c19-inh | 0.91 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.88 |
| CYP2c9-sub | 0.928 |
| CYP2d6-inh | 0.867 |
| CYP2d6-sub | 0.592 |
| CYP3a4-inh | 0.658 |
| CYP3a4-sub | 0.144 |
| CL | 2.152 |
| T12 | 0.506 |
| hERG | 0.046 |
| Ames | 0.055 |
| ROA | 0.817 |
| SkinSen | 0.812 |
| Carcinogencity | 0.867 |
| EI | 0.445 |
| Respiratory | 0.463 |
| NR-Aromatase | 0.832 |
| Antiviral | Yes |
| Prediction | 0.850774 |